Article
06 May 2026
Les aspects réglementaires et liés à la propriété intellectuelle encadrant les médicaments vétérinaires au Canada
AUTHORS CONTENT
Article
01 May 2026
Regulatory And IP Considerations For Veterinary Drugs In Canada
Article
03 Mar 2026
L'Agence des médicaments du Canada annonce une consultation sur le processus d'examen simplifié et de nouvelles procédures en ce qui concerne les reconsidérations et les nouvelles demandes d'examen
Article
03 Mar 2026
Canada's Drug Agency Announces Consultation On Streamlined Review Process And New Reconsideration/resubmission Procedures
Article
18 Dec 2025
Santé Canada et la Food and Drug Administration des États-Unis conviennent de mettre en place un programme de partage d'informations pour l'examen des médicaments génériques
Article
18 Dec 2025
Health Canada And U.S. FDA Agree To Establish Information Sharing Program For Generic Drug Submission Reviews
Article
14 Nov 2025
Santé Canada cherche à réduire le fardeau administratif en renforçant la collaboration, l'alignement et la confiance à l'échelle internationale
Article
13 Nov 2025
L'AMC ouvre une consultation sur la liste provisoire de médicaments pour guider l'élaboration d'une liste nationale de médicaments assurés
Article
26 Sep 2025
Health Canada Aims To Reduce Red Tape By Increasing International Collaboration, Alignment And Reliance
Article
08 Jul 2025
CDA Opens Consultation On Proposed List Of Drugs To Inform Development Of National Formulary
Article
01 May 2025
Canada's Drug Agency Releases 2025 Watch List Highlighting AI Technologies In Health Care
Article
03 Apr 2025
Government Of Canada Announces First Pharmacare Agreements
Article
04 Mar 2025
Minister Of Health Announces New Bilateral Agreements With Provinces For Rare Disease Drugs
Article
04 Feb 2025
Competition Tribunal Refuses JAMP Leave To Commence Ustekinumab Abuse Of Dominance Application
Article
29 Nov 2024
Federal Court Denies Motion To Add Infringement Counterclaim To Ustekinumab Impeachment Action
Article
05 Nov 2024
Government Of Canada Passes Pharmacare Act
Article
03 May 2024
Federal Court Of Appeal Dismisses Appeal Of SPRAVATO "Innovative Drug" Decision
Article
05 Mar 2024
Dexlansoprazole Formulation Patent Invalid And Not Infringed By Apotex
Article
04 Mar 2024
Federal Court Of Appeal Affirms Minister Of Health Reasonable In Concluding Successor Second Person Was Entitled To Benefit Of NOA Served By Predecessor
Article
27 Dec 2023
Certificate Of Supplementary Protection Filing Fee Increase Effective April 1, 2024
